The optimization of continuous ambulatory peritoneal dialysis

Kidney International

Volumn 55, Issue 3, 1999, Pages 1131-1149

  Oreopoulos, Dimitrios G ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

Adequacy; Chronic renal failure; Nutrition; Peritoneal dialysis

Indexed keywords

BLOOD CHEMISTRY; CLINICAL FEATURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CREATININE CLEARANCE; DISEASE DURATION; HUMAN; HYPERTENSION; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; REVIEW;

EID: 0033058639     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.0550031131.x     Document Type: Article

References (118)

1. Vas S: Nephrology Forum: Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 23:83-92, 1983
2. CANADIAN REGISTRY: Canadian Organ Replacement Register. Annual Report, 1997
3. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J-C, Laurent G: Survival as an index of adequacy of dialysis. Kidney Int 41:1286-1291, 1992
4. Diaz-Buxo JA: Is continuous ambulatory peritoneal dialysis adequate long-term therapy for end-stage renal disease? A critical assessment. J Am Soc Nephrol 3:1039-1048, 1992
5. Laird NM, Berkey CS, Lowrie EG: Modeling success or failure of dialysis therapy: The National Cooperative Dialysis Study. Kidney Int 23(Suppl 13):S101-S106, 1983
6. Gotch F, Sargent JA: A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526-534, 1985
7. Ronco C, Conz P, Agostini F, Bosch JP, Lew SQ, La Greca G: The concept of adequacy in peritoneal dialysis. Perit Dial Int 14(Suppl 3):S93-S98, 1994
8. Chen TW, Huang T-P, Liu M-C, Wang M-L: The removal index for evaluation of dialysis. Perit Dial Int 16(Suppl 2):128-134, 1996
9. Teehan BP, Schleifer CR, Brown J: Assessment of dialysis adequacy and nutrition by urea kinetic modeling. Perit Dial Int 14(Suppl 3):S99-S104, 1994
10. Rodby RA, Firan CA, Cheng Y-G, Korbet SM: Reproducibility of studies of peritoneal dialysis adequacy. Kidney Int 50:267-271, 1996
11. Ilstrup K, Hanson G, Shapiro W, Keshaviah P: Examining the foundation of urea kinetics. Trans Am Soc Artif Intern Organs 31:164-167, 1985
12. Tzamaloukas AH: In search of the ideal V. Perit Dial Int 16(Suppl 4):345-346, 1996
13. DOQI (Dialysis Outcome Quality Initiative): Clinical Practice Guidelines. New York, National Kidney Foundation, 1997
14. Blake PG: Is quantitation of dialysis by urea kinetics important in continuous ambulatory peritoneal dialysis? No. Perit Dial Int 13(Suppl 2):S212-S214, 1993
15. Keshaviah PR, Nolph KD, Van Stone JC: The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis. Perit Dial Int 9:257-260, 1989
16. Keshaviah P: Adequacy of CAPD: A quantitative approach. Kidney Int 42(Suppl 38):S160-S164, 1992
17. Lysaght MJ, Pollock CA, Hallet MD, Ibels LS, Farrell PC: The relevance of urea kinetic modeling to CAPD. Trans Am Soc Artif Intern Organs 35:784-790, 1989
18. Lameire NH: The impact of residual renal function on the adequacy of peritoneal dialysis. Nephron 77:13-28, 1997
19. Churchill DN: Outcome studies in adequacy of dialysis. Perit Dial Int 17(Suppl 3):S42-S45, 1997
20. Teehan BP, Schleifer CR, Brown JM, Sigler CR, Raimondo J: Urea kinetic analysis and clinical outcome in CAPD: A five year longitudinal study, in Advances in Peritoneal Dialysis, edited by Khanna R. Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, Toronto, Perit Dial Bull 6:181-186, 1990
21. Genestier S, Hedelin G, Schaffer P, Faller B: Prognostic factors in CAPD patients: A retrospective study of a 10 year period. Nephrol Dial Transplant 10:1905-1911, 1995
22. Maiorca R, Brunori G, Zubani R, Cancarini GC, Manili L, Camerini C, Movilli E, Pola A, D'Avolio G, Gelatti U: Predictive value of dialysis adequacy and nutritional indices for mortality and morbidity in CAPD and HD patients: A longitudinal study. Nephrol Dial Transplant 10:2295-2305, 1995
23. Churchill DN, Taylor DW, Keshaviah PR: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. CANADA-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 7(Suppl 2):198-207, 1996
24. Blake PG, Sombolos K, Abraham G, Weissgarten J, Pemberton R, Chu GL, Oreopoulos DG: Lack of correlation between urea kinetic indices and clinical outcomes in CAPD patients. Kidney Int 39:700-706, 1991
25. Harty J, Venning M, Gokal R: Does CAPD guarantee adequate dialysis and nutrition? Nephrol Dial Transplant 9:1721-1723, 1994
26. Bargman JM, Thorpe K, Churchill DN, for the CANUSA Peritoneal Dialysis Study Group: The importance of residual renal function for survival in patients on peritoneal dialysis. (abstract) J Am Soc Nephrol 8:185A, 1997
27. Pederson JA, Smith MV: Changing empiric (ERx) to kinetic (KRx) CAPD prescription: No short term effect. (abstract) Kidney Int 37:332, 1990
28. Blake P, Burkart JM, Churchill DN, Daugirdas J, Depner T, Hamburger RJ, Hull AR, Korbet SM, Moran J, Nolph KD, Oreopoulos DG, Schreiber M, Soderbloom R: Recommended clinical practices for maximizing peritoneal dialysis clearances. Perit Dial Int 6(Suppl 5):448-456, 1996
29. Boen S, Haagsma-Schouter W, Birnie R: Longterm peritoneal dialysis and peritoneal dialysis index. Nephrol Dial Transplant 7:377-378, 1978
30. Twardowski ZJ, Nolph KD, Prowant BF, Moore HL: Efficiency of high volume low frequency continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24:53-57, 1983
31. Arkouche W, Delawari E, My H, Laville M, Abdullah E, Traeger J: Quantification of adequacy of peritoneal dialysis. Perit Dial Int 13(Suppl 2):S215-S218, 1993
32. Selgas R, Bajo MA, Fernandes-Reyes MJ, Bosque E, Revuelta-Lopez K, Jimenez C, Borrego F, De Alvaro F: An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: The influence of urea and creatinine kinetics. Nephrol Dial Transplant 8:1244-1253, 1993
33. Blake PG, Balaskas EV, Izatt S, Oreopoulos DG: Is total creatinine clearance a good predictor of clinical outcomes in continuous ambulatory peritoneal dialysis? Perit Dial Int 12:353-358, 1992
34. Chen HH, Shetty A, Afthentopoulos IE, Oreopoulos DG: Discrepancy between weekly Kt/V and weekly creatinine clearance in patients on CAPD, in Advances in Peritoneal Dialysis, edited by Khanna R. Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, Toronto, Perit Dial Bull 11:83-87, 1995
35. Harty J, Boulton H, Heelis N, Uttley L, Venning M, Gokal R: Limitations of kinetic models as predictors of nutritional dialysis adequacy in continous ambulatory peritoneal dialysis patients. Am J Nephrol 13:454-463, 1993
36. Nolph KD, Twardowski ZJ, Keshaviah PR: Weekly clearance of urea and creatinine on CAPD and NIPD. Perit Dial Int 12:298-303, 1992
37. Vonesh EF, Burkart J, McMurray SD, Williams PF: Peritoneal dialysis kinetic modeling: Validation in a multicenter clinical study. Perit Dial Int 16:471-481, 1996
38. Lindsay RM, Spanner E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 13:382-389, 1989
39. Enia G, Sicuso C, Alati G, Zocalli C: Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8:1094-1098, 1993
40. Heimburger O, Bergström J, Lindholm B: Albumin and amino acid levels as markers of adequacy in continuous ambulatory peritoneal dialysis. Perit Dial Int 14(Suppl 3):S123-S132, 1994
41. Panzetta G, Tessitore N, Faccini G, Maschio G: The catabolic rate as a measure of protein intake in dialysis patients: Usefulness limits. Nephrol Dial Transplant 5(Suppl1):125-127, 1990
42. Bingham SA, Cummings JM: Urine nitrogen as an independent validatory measure of dietary intake: A study of nitrogen balance in individuals consuming their normal diet. Am J Clin Nutr 42:1276-1289, 1985
43. Keshaviah PR, Nolph KD: Protein catabolic rate calculations in CAPD patients. ASAIO Trans 37:M400-M402, 1991
44. Bergström J, Furst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients with continuous ambulatory peritoneal dialysis. Kidney Int 44:1048-1057, 1993
45. Bergström J, Heimbürger O, Lindholm B: Calculation of the protein equivalent of total nitrogen appearance from urea appearance: which formulas should be used? Perit Dial Int 18:467-473, 1998
46. Kopple JK, Xui-Lin G, Qing DP: Dietary protein, urea nitrogen appearance and total nitrogen appearance in chronic renal failure and CAPD patients. Kidney Int 52:486-494, 1997
47. Mandolfo S, Zucchi A, Cavalieri D'Oro L, Corradi B, Imbasciati E: Protein nitrogen appearance in CAPD patients: What is the best formula? Nephrol Dial Transplant 11:1592-1596, 1996
48. Harty JC, Boulton H, Curwell J, Heelis N, Uttley L, Venning MC, Gokal R: The normalized protein catabolic rate is a flawed marker of nutrition in CAPD patients. Kidney Int 45:103-109, 1994
49. Canaud B, Leblanc M, Garred LJ, Bosc J-Y, Argiles A, Mion C: Protein catabolic rate over lean body mass ratio: A more rational approach to normalize the protein catabolic rate in dialysis patients. Am J Kidney Dis 30:672-679, 1997
50. Blake PG, Oreopoulos DG: Answers to all your questions about peritoneal urea clearance and nutrition in CAPD patients. Perit Dial Int 16:248-251, 1996
51. Lameiri NH, Vanholder R, Veyt D, Lambert MC, Ringoir S: A longitudinal, five year survey of urea kinetic parameters in CAPD patients. Kidney Int 42:426-432, 1992
52. Krediet RT, Koomen GCM, Struijk DG, Van Olden RW, Imholz ALT, Boeschoten EW: Practical methods for assessing dialysis efficiency during peritoneal dialysis. Kidney Int 46(Suppl 48):S7-S13, 1994
53. McCusker FX, Teehan BP, Thorpe KE, Keshaviah PR, Churchill DN, for the Canada-USA (CANUSA) Peritoneal Dialysis Study Group: How much peritoneal dialysis is required for maintenance of a good nutritional state? Kidney Int 50:(Suppl 56):S56-S61, 1996
54. Ikizler TA, Greene JH, Wingard RL, Parker RA, Hakim RM: Spontaneous dietary protein intake during progression of chronic renal failure. J Am Soc Nephrol 6:1386-1391, 1995
55. Bergström J, Mamoun H, Anderstam B, Sodersten P: Middle molecules (MM) isolated from uremic ultrafiltrate (UF) and normal urine induce dose-dependent inhibition of appetite in the rat. (abstract) J Am Soc Nephrol 5:488, 1994
56. Bergström J: Nutrition and mortality in hemodialysis. J Am Soc Nephrol 6:1329-1341, 1995
57. Gokal R, Harty J: Are there limits for CAPD? Adequacy and nutritional considerations. Perit Dial Int 16:437-441, 1996
58. Nolph KD, Moore HL, Prowant B, Meyer M, Twardowski ZJ, Khanna R, Ponferrada L, Keshaviah P: Cross-sectional assessment of weekly urea and creatinine clearance and indices of nutrition in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 13:178-183, 1993
59. Blumenkrantz MJ, Kopple JD, Moran JK, Coburn JW: Metabolic balance studies and dietary protein requirements in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 21:849-861, 1982
60. Bergström J, Lindholm B: Nutrition and adequacy of dialysis: How do hemodialysis and CAPD compare? Kidney Int 43(Suppl 40):S39-S50, 1993
61. Uehlinger DE: Another look at the relationship between protein intake and dialysis dose. J Am Soc Nephrol 7:166-168, 1996
62. Blake PG, Lindsay RM, Spanner E, Heidenheim P, Baird J, Allison M, Oreopoulos DG: Factors modifying the relationship between Kt/V urea and normalized protein catabolic rate (PCRN) in CAPD. (abstract) J Am Soc Nephrol 4:398, 1993
63. Nolph ND, Keshaviah P, Emerson P, Van Stone JC, Twardowski ZJ, Khanna R, Moore HL, Collins A, Edwards A: A new approach to optimizing urea clearance in hemodialysis and continuous ambulatory peritoneal dialysis. ASAIO J 41:M446-M451, 1995
64. Ronco C: Adequacy of peritoneal dialysis is more than Kt/V. Nephrol Dial Transpl 12(Suppl 1):68-73, 1997
65. Panzetta G: Protein intake does not depend on the dose of dialysis delivered - provided Kt/V is adequate. Nephrol Dial Transplant 10:2286-2289, 1995
66. Lindsay RM, Spanner E, Heidenheim P, Kortas C, Blake PG: PCR, Kt/V and membrane. Kidney Int 43(Suppl 41):S268-S278, 1993
67. Bernardini J, Piraino B: Urea kinetics and nitrogen appearance rates in diabetic patients on peritoneal dialysis. Perit Dial Int 15:259-263, 1995
68. Gotch F: A positive correlation of PCRN to Kt/V in cross sectional studies is not a proof of causal relationship. Perit Dial Int 15:274-275, 1995
69. Lindsay RM, Spanner E, Heidenheim RP, Lefebvre JM, Hodsman A, Baird J, Allison MEM: Which comes first, Kt/V or PCR: Chicken or egg? Kidney Int 42(Suppl 38):S32-S36, 1992
70. Heimburger O, Tranaeus A, Bergström J, Lindholm B: The effect of increased PD on Kt/V, protein calabolic rate (PCR) and serum albumin. (abstract) Perit Dial Int 12(Suppl 1):S19, 1992
71. Burkart J, Jordan J, Garchow S, Jones M: Using a computer kinetic modeling program to prescribe PD. (abstract) Perit Dial Int 13(Suppl 4):S77, 1993
72. Uribarri J, Dimaano F, London RD, Dowling J, Marcus RG: Increase in Kt/V increased serum albumin but not nPCR in a group of patients on continuous peritoneal dialysis. Perit Dial Int 17:511-513, 1997
73. Davies SJ, Phillips L, Griffiths A, Naish PF, Russell GI: Impact of increasing Kt/V in malnourished CAPD patients. (abstract) J Am Soc Nephrol 8:262A, 1997
74. Lynn RI, Fishbane S, Ginsberg NS: The effect of Kt/V urea on nitrogen appearance and appetite in peritoneal dialysis. Perit Dial Int 15(Suppl 5):S50-S52, 1995
75. Williams P, Jones J, Marriott J: Do increases in dialysis dose in CAPD patients lead to nutritional improvements? Nephrol Dial Int 9:1841-1842, 1994
76. Harty J, Faragher B, Venning M, Gokal R: Urea kinetic modeling exaggerates the relationship between nutrition and dialysis in CAPD patients. (The hazards of cross-sectional analysis). Perit Dial Int 15:105-109, 1995
77. Malhotra D, Tzamaloukas AH, Murata GH, Fox L, Goldman RS, Avasthi PS: Serum albumin in continous peritoneal dialysis: Its predictors and relationship to urea clearance. Kidney Int 50:243-249, 1996
78. Dombros NV, Digenis GE, Soliman G, Oreopoulos DG: Anabolic steroids in the treatment of malnourished CAPD patients: A retrospective study. Perit Dial Int 14:344-347, 1994
79. Lameire N, Vanholder RC, Van Loo A, Lambert M-C, Vijt D, Bockstaele VL, Vogeleere P, Ringoir SM: Cardiovascular diseases in peritoneal dialysis patients: The size of the problems. Kidney Int 50(Suppl 56):S28-S36, 1996
80. Coles GA: Have we underestimated the importance of fluid balance for the survival of PD patients? Perit Dial Int 17:321-326, 1997
81. Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal disease. Kidney Int 49:1379-1385, 1996
82. Ritz E, Koch M: Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 21(Suppl 2):113-118, 1993
83. Heimburger O, Waniewski J, Verynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-506, 1990
84. Coles GA, Williams JD: The management of ultrafiltration failure in peritoneal dialysis. Kidney Int 46(Suppl 48):S14-S17, 1994
85. Rottemburg J: Residual renal function and recovery of renal function in patients treated by CAPD. Kidney Int 43(Suppl 40):S106-S110, 1993
86. Lauster F, Heim JM, Drummer C, Fülle H-J, Gerzer R, Schiffe H: Plasma cGMP level as a marker of the hydration state in renal replacement therapy. (abstract) Kidney Int 43(Suppl 41):S57, 1993
87. Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, Nielsen MP: Peritoneal equilibration test. Perit Dial Bull 7:138-147, 1987
88. Nolph KD, Moore HL, Prowant BF, Twardowski NJ, Khanna R, Gamboa S, Keshaviah P: Continuous ambulatory peritoneal dialysis with high flux membrane. ASAIO J 39:904-909, 1993
89. Churchill DN, Thorpe KE, Nolph KD, Keshaviah PR, Oreopoulos DG, Page D, for the Canada USA (CANUSA) Peritoneal. Dialysis Study Group: Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J Am Soc Nephrol 9:1285-1292, 1998
90. Blake PG: What is the problem with high transporters? Perit Dial Int 17:317-320, 1997
91. Bergström J, Lindholm B: Malnutrition, cardiac disease, and mortality: An integrated point of view. Am J Kidney Dis 32: 834-841, 1998
92. Blake PG, Korbet S, Blake R, Bargman J, Burkart J, Dasgupta M, Delano B, Fine A, Finkelstein F, McCusker F: Admitted noncompliance (NC) with CAPD exchanges is more common in US than Canadian patients. (abstract) J Am Soc Nephrol 8:278A, 1997
93. Diaz-Buxo JA: Enhancement of peritoneal dialysis: The PD plus concept. Am J Kidney Dis 27:92-98, 1996
94. Schoenfeld P, Diaz-Buxo J, Keen M, Gotch FA: The effect of body position (P), surface area (BSA), and intraperitoneal exchange volume (Vip) on the peritoneal transport constant (KpA). (abstract) J Am Soc Nephrol 4:416, 1993
95. Keshaviah P, Emerson PF, Vonesh EF, Brandes JC: Relationship between body size, fill volume, and mass transfer area coefficient in peritoneal dialysis. J Am Soc Nephrol 4:1820-1826, 1994
96. Brandes JC, Packard WJ, Watters SK, Fritsche C: Optimization of dialysate flow and mass transfer during automated peritoneal dialysis. Am J Kidney Dis 25:603-610, 1995
97. Piraino B, Bender F, Bernardini J: A comparison of clearances on tidal peritoneal dialysis and intermittent peritoneal dialysis. Perit Dial Int 14:145-148, 1994
98. Nolph DK: Has peritoneal dialysis peaked? The impact of the CANUSA Study. ASAIO J 42:136-138, 1996
99. Tattersall JE, Greenwood R, Farrington K: Urea kinetics and when to commence dialysis. Am J Nephrol 15:283-289, 1995
100. Tattersall JE, Doyle S, Greenwood RN, Farrington K: Kinetic modelling and underdialysis in CAPD patients. Nephrol Dial Transplant 8:535-538, 1993
101. Ganz G, Singh S, Djurdiev O, Levin A: Current dialysis practices in British Columbia, a cross-sectional study. (abstract) J Am Soc Nephrol 8:193A, 1997
102. Kaysen GA, Schoenfeld PY: Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 25:107-114, 1984
103. Winchester JF: The albumin dilemma. Am J Kidney Dis 20:76-77, 1992
104. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG: Serum albuminemia in patients on continuous ambulatory peritoneal dialysis - predictors and correlations with outcomes. J Am Soc Nephrol 3:1501-1507, 1993
105. Han DS, Lee SW, Kang SW, Choi KM, Lee HY, Cho EY, Lee JH: Factors affecting low values of serum albumin in CAPD patients, in Advances in Peritoneal Dialysis, edited by Khanna R. Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, Toronto, Perit Dial Publications 12:288-292, 1996
106. Yeun JY, Kaysen GA: Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 30:923-927, 1997
107. Oreopoulos DG, Crassweller P, Katirtzoglou A, Ogilvie R, Zellerman G, Rodela H, Vas SI: Amino acids as an osmotic agent (instead of glucose) in continuous ambulatory peritoneal dialysis, in Continuous Ambulatory Peritoneal Dialysis, edited by Legrain E, Amsterdam, Excerpta Medica, 1979, pp 335-340
108. Kopple JD, Bernard D, Messana J, Swartz R, Bergström J, Lindholm B, Lim V, Brunori G, Leiserowitz M, Bier DM, Stegink LD, Martis L, Boyle CA, Seskes KD, Vonesh E, Jones MR: Treatment of malnourished CAPD patients with amino acid based dialysate. Kidney Int 47:1148-1157, 1995
109. Jones M, Hamburger R, Charytan C, Sandronis S, Bernard D, Piraino B, Schreiber M, Gehr T, Fein P, Friedlander M, Burkart J, Ross D, Zimmerman S, Swartz R, Knight T, Kraus A, McDonald L, Hartnett M, Weaver M, Hagen T, Vonesh E, Algrim Boyle C, Piscopo D, Martis L, Moran J: Treatment of malnutrition in peritoneal dialysis (PD) patients with 1.1% amino-acid (AA) dialysate solution. (abstract) Perit Dial Int 15:S42, 1995
110. Afthentopoulos IE, Oreopoulos DG: Is CAPD an effective treatment for ESRD patients with a weight over 80 kg? Clin Nephrol 47:389-393, 1997
111. Kopple JD, Lew NL, Zhu X, Lowrie EG: Body weight predicts mortality in maintenance hemodialysis (MHD) patients. (abstract) J Am Soc Nephrol 8:198A, 1997
112. Rocco MV, Jordan JR, Burkart MJ: Changes in peritoneal transport during the first month of peritoneal dialysis. Perit Dial Int 15:12-17, 1995
113. Bloembergen WE, Port KF, Manger A, Wolfe RA: A comparison of mortalities between patients treated with hemodialysis and peritoneal dialysis. J Am Soc Nephrol 6:177-183, 1995
114. Fenton SSA, Schaubel DE, Desmeules M, Morrison HI, Mao Y, Copleston P, Jeffrey JR, Kjellstrand CM: A comparison of adjusted mortality rates. Am J Kidney Dis 30:334-342, 1997
115. Bernardini J, Piraino B: Measuring compliance with prescribed exchanges in CAPD and CCPD patients. Perit Dial Int 17:338-342, 1997
116. Vonesh E, Moran J: Further comparisons of mortality between hemodialysis (HD) and peritoneal dialysis (PD). (abstract) Perit Dial Int 18(Suppl 1):S56, 1998
117. Peers E, Gokal R: Icodextrin: Overview of clinical experience. Perit Dial Int 17:22-26, 1997
118. Nissenson AR, Prichard SS, Cheng IKP, Gokal R, Kubota M, Maiorca R, Riella MC, Rottenbourg J, Stewart JH: Nonmedical factors that impact on ESRD modality selection. Kidney Int 43(Suppl):S120-S127, 1993